Bioline Reagents Limited
04838884
Some Concerns
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
- 4 outstanding charges (-8)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 23/03/2022
CHIEF FINANCIAL OFFICER
AMERICAN · UNITED STATES · Age 47
Also on 1 other board
Persons with Significant Control
Meridian Bioscience International Limited
16, Edge Business Centre, Humber Road, London, NW2 6EW
Reg: 8971622 · England And Wales · Limited Company
Notified 06/04/2016
Charges4 outstanding
STANDARD CHARTERED BANK AS THE SECURITY AGENT
STANDARD CHARTERED BANK AS THE SECURITY AGENT
PNC BANK, NATIONAL ASSOCIATION, AS AGENT AND TRUSTEE FOR ITSELF AND THE OTHER SECURED PARTIES (
PNC BANK, NATIONAL ASSOCIATION
CompanyRankvs 31+ SIC 20590 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/12/2024
Turnover
£17.1M
Annual revenue
Net Worth
£7.8M
Balance sheet strength
Cash
£2.8M
Cash in the bank
Profit Before Tax
£9.4M
Bottom line earnings
Net Current Assets
£7.5M
Working capital
Current Assets
£9.4M
Current Liabilities
£1.9M
Fixed Assets
£259k
Debtors
£6.1M
Cost of Sales
£2.7M
Gross Profit
£14.4M
Admin Expenses
£5.1M
Operating Profit
£9.5M
Profit After Tax
£7.0M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 5.02 | +£990k |
| 2023 | 3.32 | -£12.8M |
| 2021 | 7.91 | — |
Derived from filed accounts. Not audited figures.